Skip to main content
Chemtai-Mungo-Pharmacokinetics-Intravaginal-artesunate-vaginal-pessaries
Chemtai Mungo, MD, MPH, FACOG

Chemtai Mungo, MD, MPH, FACOG, has been awarded $2.5M over five years by the National Institutes of Health for her research focused on improving human papillomavirus (HPV) treatment outcomes in women living with HIV (WWH) in Africa. Dr. Mungo is an Assistant Professor in the UNC Department of Obstetrics and Gynecology, Affiliate Faculty in Lineberger Comprehensive Cancer Center, and a member of the UNC Institute for Global Health and Infectious Diseases.

Dr. Mungo’s primary research is centered on increasing access to effective, evidence-based cervical cancer prevention in low-income countries, including investigating resource-appropriate and effective methods of treating cervical precancer. “My journey began witnessing the devastating effects of preventable cervical cancer deaths in rural Kenya, where poverty and fragile health systems make cancer care unattainable,” says Dr. Mungo.

Read more.